This maybe because your body doesn't metabolize medications to work optimally and get you better. The good news is that we now have a new screening test that eliminates guess work when prescribing medications. No when you take a medication, with this test, we know if your body can metabolize the medication and if this treatment will be effective. This is very very exciting as it decreases the amount of medications that we prescribe and gets our patients better faster! Our office can now personalize drug therapy by identifying patients’ drug metabolizing phenotypes for improved efficacy and reduced adverse drug events (ADE).
In fact some food for thought:
- To identify the likelihood of an ADE.
- An estimated 20-30% of pain patients have a genetic opioid (GOMD) metabolic defect.
- 2.2 billion ADE occur yearly with over 100,000 cases resulting in death.
- To increase drug efficacy.
- Only 58% of patients who take prescription pain medication receive relief.
- Patients with reduced-function alleles have a 3.5–8 times greater risk for major adverse cardiovascular events, with greatest risk in poor metabolizers of Plavix.
- Drug treatment of psychiatric disorders is troubled by severe adverse effects, low compliance and lack of efficacy in about 30 percent of patients.
- To improve patient compliance.
- Knowledge of their genetic test results has been proven to make patients more likely to take medications as prescribed.
- To reduce healthcare costs by preventing ADE.
- An estimated $136 billion is spent on treating ADE annually.
- Prescription opioid analgesics are among the most common causes of ADE
Looking at these statistics it is clear why this test is essential to each individual. Call our office today to schedule your appointment!